Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT
Clinical trial NCT04858776 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04858776
- Sponsor
- Mercator MedSystems, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-08
- Primary completion
- 2025-08-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.